www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News Urgent: Sharon wins Shinui support for 2005 budget    Urgent: More than 10 people injured in Beirut explosion    FLASH: LARGE EXPLOSION HEARD IN BERUT    URGENT: Russia grants asylum to ousted Kyrgyz president    FLASH: 2 KILLED, 12 INJURED IN PLANE CRASH IN WESTERN CARIBBEAN    Urgent: U.S. agrees to sell F-16s to Pakistan    
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Source Manufacturers and Suppliers from China and around the world
   News Photos Voice People BizChina Feature About us   
Novel compound may promise therapy for cat allergies
www.chinaview.cn 2005-03-28 10:55:21

    LOS ANGELES, March 27 (Xinhuanet) -- A molecule designed to block cat allergies successfully prevented allergic reactions in laboratory mice as well as in human cells in tests, US researchers said Sunday.

    In a paper in the April issue of the journal Nature Medicine, scientists at the University of California Los Angeles (UCLA) said these promising results could lead to a new therapy not only for human cat allergies, but also possibly for severe food allergies such as those to peanuts.

A molecule designed to block cat allergies successfully prevented allergic reactions in laboratory mice as well as in human cells in tests, US researchers said Sunday.

A molecule designed to block cat allergies successfully prevented allergic reactions in laboratory mice as well as in human cells in tests.
 
    
The injectable treatment puts a brake on the release of a key chemical from cells involved in cat allergy reactions. That chemical, histamine, brings on allergy symptoms such as sneezing, wheezing, itching, watery eyes and sometimes asthma.

    When a cat-allergic person touches or inhales a protein found in cat saliva or dander, key immune system cells respond by spewing out histamine. Experts estimate that 14 percent of children 6 to 19 years old are allergic to cats.

    The treatment comprises a molecule that loosely links a feline and a human protein together. The feline end is a protein called Fel d1 found in cat dander and saliva that causes so much misery in allergy sufferers. On the other end sits a piece of human antibody that docks to a cell receptor that can be recruited to stop allergic reactions.

    The investigators named the molecule GFD, or Gamma Feline Domesticus, for its human and feline parts, according to lead scientist Andrew Saxon of UCLA. The cat allergen end of GFD binds to antibodies on the surface of the cell. The human end of GFD links to a different cell surface protein that interrupts the allergic response.

    Saxon's team first tested GFD in blood donated by people allergic to cats. Scientists cultured blood cells with either GFD or with a purified human antibody as a control. Then they added the cat protein that triggers allergic reactions to all the blood cell cultures.

    "We measured more than 90 percent less histamine in the cultures with GFD," they wrote in the paper, "those results suggested that GFD successfully prevented the immune cells from reacting to cat allergen. The next step was to test GFD in mice that we had made allergic to the allergenic protein found in cat saliva and dander."

    The researchers tested GFD in two different types of allergic mice. One set was genetically engineered to have human cat-allergy cell receptors. These mice would react to cat protein only after the scientists first injected them with human allergic antibodies to cats.

    When these mice were injected with cat allergen, GFD blocked the allergic reaction involving the human cell receptors, an indication that it might also work in people.

    Scientists made another set of mice allergic to cats by injecting them with cat protein and an immune system booster. Their reactions to cat allergen would be comparable to reactions in a cat-allergic person.

    Then scientists injected some of these mice with GFD, and injected cat allergen into the windpipes of all the mice, including a control group that was not allergic to cats. They found GFD damped asthma-like and other allergic reactions in the cat-allergic mice.

    The molecule has the potential to prevent allergic reactions long after injections cease, scientists said.

    "This novel approach to treating cat allergies is encouraging news for millions of cat-allergic Americans. Moreover, these results provide proof-of-concept for using this approach to develop therapies to prevent deadly food allergy reactions as well," commented Anthony S. Fauci, head of US National Institute of Allergy and Infectious Diseases.

    However, further research and clinical testing would be required before it might be used in humans, Saxon noted. Enditem

  Related Story
Jolie voted world's sexiest woman
Video claims killing of Iraqi official
Winners at 24th Hong Kong Film Awards
- Chinese in Bishkek hit by looters
- Asian immigrants drown, abandoned by smugglers
- Tibetan antelope tipped as Olympic mascot
- New method may stop HIV spreading
- Attorneys: Schiavo legal battle nears end
- Chinese warned against travel to Kyrgyzstan
- About half Russians feel free: poll
- China to end govt bailout for bankrupt SOEs
- Lebanese president pledges to end violence
- Video shows car linked to Hariri killing
- Abbas criticizes Israeli settlement policy
- Iran rejects Egyptian verdict against diplomat for spying
- About half Russians feel free: poll
- Czech PM re-elected as party chairman
- Asian immigrants drown, abandoned by smugglers
- Ousted Kyrgyz leader allowed to go to Russia
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.